All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Patients with Breast Cancer Following Adjuvant Chemotherapy with Anthracycline and Taxane

DOI: 10.4236/oalib.1105999, PP. 1-6

Subject Areas: Oncology

Keywords: Breast Cancer, Chemotherapy-Induced Amenorrhea, Adjuvant Anthracycline and Taxane-Based Chemotherapy

Full-Text   Cite this paper   Add to My Lib

Abstract

Breast cancer (BC) is the second incidence and the fifth leading cause to cancer death in the worldwide. In developing countries, the number of BC cases is still increased annually accompanied with the changes of lifestyle and screening programs. Nevertheless, the majority of BC patients are diagnosed as non-curative stage. Thereby, systemic therapy always plays an important role in BC treatment strategies. Among chemotherapy regimens, the combination of anthracyclin and taxane as an adjuvant treatment has been proven the efficacy and safety in terms of prolonging survival. In this study, we evaluated the incidence of chemotherapy-induced amenorrhea in breast cancer patients who were treated with adjuvant anthracycline and taxane-based chemotherapy.

Cite this paper

Quang, N. T. , Anh, P. T. , Quang, L. V. , Hai, N. V. , Huan, N. D. , Tin, N. C. , Tam, N. T. T. , Hang, H. T. , Thuy, N. T. , Mai, D. T. T. , Nam, T. H. and Hanga, L. T. (2020). Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Patients with Breast Cancer Following Adjuvant Chemotherapy with Anthracycline and Taxane. Open Access Library Journal, 7, e5999. doi: http://dx.doi.org/10.4236/oalib.1105999.

References

[1]  https://gco.iarc.fr/today/online-analysis-multi
-bars?v=2018&mode=cancer&mode_popula
tion=countries&population=900&population
s=900&key=total&sex=0&cancer=39&type
=0&statistic=5&prevalence=0&population_
group=0&ages_group%5B%5D=0&ages_gr
oup%5B%5D=17&nb_items=10&group_ca
ncer=1&include_nmsc=1&include_nmsc_oth
er=1&type_multiple=%257B%2522inc%25
22%253Atrue%252C%2522mort%2522%2
53Atrue%252C%2522prev%2522%253Afa
lse%257D&orientation=horizontal&type_so
rt=1&type_nb_items=%257B%2522top%2
522%253Atrue%252C%2522bottom%2522
%253Afalse%257D&population_group_globo
can_id=
[2]  Fornier, M.N., Modi, S., Panageas, K.S., Norton, L. and Hudis, C. (2005) Incidence of Chemotherapy-Induced, Long-Term Amenorrhea in Patients with Breast Carcinoma Age 40 Years and Younger after Adjuvant Anthracycline and Taxane. Cancer, 104, 1575-1579.
https://acsjournals.onlinelibrary.wiley.com/d
oi/full/10.1002/cncr.21385
https://doi.org/10.1002/cncr.21385
[3]  Walshe, J.M., Denduluri, N. and Swain, S.M. (2006) Amenorrhea in Premenopausal Women after Adjuvant Chemotherapy for Breast Cancer. Journal of Clinical Oncology, 24, 5769-5779.
https://ascopubs.org/doi/abs/10.1200/JCO.20
06.07.2793?journalCode=jco
https://doi.org/10.1200/JCO.2006.07.2793
[4]  Jeon, S.J., Lee, J.I., Jeon, M.J. and Lee M. (2016) Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients. Medicine, 95, e3301.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998816/
https://doi.org/10.1097/MD.0000000000003301
[5]  Thang, V.H. (1999) Clinical and Pathology Cheresteristics of Stage I-II-III of Breast Cancer. Vietnam Journal of Oncology, 8, 54-57.
[6]  Hung, N.C. and Thiep, T.V. (1999) Diagnosis and Treatment of Breast Cancer in Ho Chi Minh Oncology Hospital. Vietnam Journal of Oncology, 12, 197-206.
[7]  Giuliano, A.E., Haigh, P.I., Brennan, M.B., Hansen, N.M., Kelley, M.C., Ye, W., Glass, E.C. and Turner, R.R. (2000) Prospective Observational Study of Sentinel Lymphadenectomy without Further Axillary Dissection in Patients with Sentinel Node-Negative Breast Cancer. Journal of Clinical Oncology, 18, 2553-2559.
https://ascopubs.org/doi/10.1200/JCO.2000.18.13.2553
https://doi.org/10.1200/JCO.2000.18.13.2553
[8]  Choi, S.H., Barsky, S.H. and Chang, H.R. (2003) Clinicopathologic Analysis of Sentinel Lymph Node Mapping in Early Breast Cancer. The Breast Journal, 9, 153-162.
https://onlinelibrary.wiley.com/doi/abs/10.1
046/j.1524-4741.2003.09304.x
https://doi.org/10.1046/j.1524-4741.2003.09304.x
[9]  Tham, Y.L., Sexton, K., Weiss, H., Elledge, R., Friedman, L.C. and Kramer, R. (2007) The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated with Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane. American Journal of Clinical Oncology, 30, 126-132.
https://insights.ovid.com/crossref?an=000
00421-200704000-00004
https://doi.org/10.1097/01.coc.00002513
98.57630.4f
[10]  Berliere, M., Dalenc, F., Malingret, N., Vindevogel, A., Piette, P., Roche, H., Donnez, J., Symann, M, Kerger, J. and Machiels, P. (2008) Incidence of Reversible Amenorrhea in Women with Breast Cancer Undergoing Adjuvant Anthracycline-Based Chemotherapy with or without Docetaxel. BMC Cancer, 8, 56.
https://bmccancer.biomedcentral.com/arti
cles/10.1186/1471-2407-8-56
https://doi.org/10.1186/1471-2407-8-56
[11]  Goldhirsch, A., Gelber, R.D. and Castiglione, M. (1990) The Magnitude of Endocrine Effects of Adjuvant Chemotherapy for Premenopausal Breast Cancer Patients. Annals of Oncology, 1, 183-188.
https://academic.oup.com/annonc/article-abst
ract/1/3/183/146536?redirectedFrom=fulltext
https://doi.org/10.1093/oxfordjournals.annonc.a
057718

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal